A Randomized Controlled Trial Comparing the Safety and Efficacy of IDegLira Versus Basal Bolus in Patients With Poorly Controlled Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2019
Price : $35 *
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin aspart; Insulin degludec; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IDegLira HIGH Trial
- 24 Jan 2019 Status changed from not yet recruiting to recruiting.
- 17 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019.
- 17 Nov 2018 New trial record